Literature DB >> 16616012

Effects of omega-3 fatty acids on resting heart rate, heart rate recovery after exercise, and heart rate variability in men with healed myocardial infarctions and depressed ejection fractions.

James H O'Keefe1, Hussam Abuissa, Antonio Sastre, David M Steinhaus, William S Harris.   

Abstract

We explored possible mechanisms by which recommended intakes of omega-3 fatty acids may decrease the risk for sudden cardiac death in patients with documented coronary heart disease. The cardioprotective effects of omega-3 fatty acids have been documented in epidemiologic and randomized controlled trials. These fatty acids are presumed to decrease susceptibility to fatal arrhythmias, but whether this is mediated by classic risk factors or direct cardiac mechanisms is not known. Eighteen white men with a history of myocardial infarction and ejection fractions <40% were randomized to placebo or omega-3 fatty acids (585 mg of docosahexaenoic acid and 225 mg of eicosapentaenoic acid) for two 4-month periods in a crossover design. At the end of each period, heart rate (HR), HR variability, and rate of HR recovery after exercise were determined, as were effects on arterial compliance, blood pressure, cardiac function, and fasting serum levels of lipids and inflammatory markers. Omega-3 fatty acids decreased HR at rest from 73 +/- 13 to 68 +/- 13 beats/min (p <0.0001) and improved 1-minute HR recovery after exercise (-27 +/- 10 to -32 +/- 12 beats/min, p <0.01). HR variability in the high-frequency band increased (p <0.02), but no change was noted in overall HR variability. There were no significant effects on blood pressure, arterial compliance, lipids, or inflammatory markers. These changes are consistent with an increase in vagal activity and may in part explain the observed decrease in risk for sudden cardiac death seen with omega-3 fatty acid supplementation.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16616012     DOI: 10.1016/j.amjcard.2005.11.025

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  48 in total

1.  Clinical correlates and heritability of erythrocyte eicosapentaenoic and docosahexaenoic acid content in the Framingham Heart Study.

Authors:  William S Harris; James V Pottala; Sean M Lacey; Ramachandran S Vasan; Martin G Larson; Sander J Robins
Journal:  Atherosclerosis       Date:  2012-06-07       Impact factor: 5.162

Review 2.  Fish oil in critical illness: mechanisms and clinical applications.

Authors:  Renee D Stapleton; Julie M Martin; Konstantin Mayer
Journal:  Crit Care Clin       Date:  2010-07       Impact factor: 3.598

Review 3.  Fish-oil supplementation in patients with implantable cardioverter defibrillators: a meta-analysis.

Authors:  David J A Jenkins; Andrea R Josse; Joseph Beyene; Paul Dorian; Michael L Burr; Roxanne LaBelle; Cyril W C Kendall; Stephen C Cunnane
Journal:  CMAJ       Date:  2008-01-15       Impact factor: 8.262

4.  Effects of fatty and lean fish intake on blood pressure in subjects with coronary heart disease using multiple medications.

Authors:  Arja T Erkkilä; Ursula S Schwab; Vanessa D F de Mello; Tiina Lappalainen; Hanna Mussalo; Seppo Lehto; Virpi Kemi; Christel Lamberg-Allardt; Matti I J Uusitupa
Journal:  Eur J Nutr       Date:  2008-07-29       Impact factor: 5.614

5.  The russert impact: a golden opportunity to promote primary coronary prevention.

Authors:  Carl J Lavie; Richard V Milani; James H O'Keefe
Journal:  Ochsner J       Date:  2008

6.  Fetal cardiac autonomic control during breathing and non-breathing epochs: the effect of maternal exercise.

Authors:  Kathleen M Gustafson; Linda E May; Hung-wen Yeh; Stephanie K Million; John J B Allen
Journal:  Early Hum Dev       Date:  2012-01-20       Impact factor: 2.079

7.  Omega-3 fatty acid supplementation enhances stroke volume and cardiac output during dynamic exercise.

Authors:  Buddy Walser; Charles L Stebbins
Journal:  Eur J Appl Physiol       Date:  2008-06-18       Impact factor: 3.078

8.  Impaired signaling intrinsic to sinoatrial node pacemaker cells affects heart rate variability during cardiac disease.

Authors:  Yael Yaniv; Alexey E Lyashkov; Edward G Lakatta
Journal:  J Clin Trials       Date:  2014-03

Review 9.  Omega-3 ethylester concentrate: a review of its use in secondary prevention post-myocardial infarction and the treatment of hypertriglyceridaemia.

Authors:  Sheridan M Hoy; Gillian M Keating
Journal:  Drugs       Date:  2009-05-29       Impact factor: 9.546

10.  Effects of omega-3 fatty acid supplementation on heart rate variability at rest and during acute stress in adults with moderate hypertriglyceridemia.

Authors:  Katherine A Sauder; Ann C Skulas-Ray; Tavis S Campbell; Jillian A Johnson; Penny M Kris-Etherton; Sheila G West
Journal:  Psychosom Med       Date:  2013-04-16       Impact factor: 4.312

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.